Testo Blend 350 mg is an oil-based testosterone blend injectable manufactured by Dragon Pharma and dosed at 350 mg/mL in a 10 mL vial, combining three testosterone esters for a multi-phase release profile.
Testo Blend 350 mg is an injectable anabolic-androgenic steroid containing a blend of three testosterone esters: testosterone propionate (50 mg), testosterone cypionate (100 mg), and testosterone enanthate (200 mg). This multi-ester formulation is designed to provide both rapid and extended testosterone release after a single injection, with the short-acting propionate delivering an initial peak and the longer-acting cypionate and enanthate esters sustaining testosterone levels over time.
In clinical practice, multi-ester testosterone blends were developed to provide more stable testosterone levels with less frequent injections for testosterone replacement therapy. In bodybuilding and performance-enhancement settings, Testo Blend 350 mg is commonly used as a foundation compound in mass-building or bulking cycles because of its anabolic and androgenic activity, though such use falls outside approved medical indications. The 350 mg/mL concentration delivers a higher amount of testosterone per milliliter compared to standard 250 mg/mL preparations.
Testosterone supports processes involved in muscle protein synthesis, recovery, strength, sexual function and maintenance of normal male physiological characteristics. When testosterone is used at supraphysiologic levels for physique or performance enhancement, however, the potential for adverse effects also increases and such use falls outside approved medical indications.
Testo Blend 350 mg uses MCT oil as its carrier oil, providing the oil base for the three-ester testosterone blend.
Testo Blend 350 mg is a multi-ester testosterone preparation designed to provide both rapid and extended release after a single injection. Its blend profile distinguishes it from single-ester testosterone preparations.
The three esters in Testo Blend 350 mg differ primarily in their rate of release from the injection site. Testosterone propionate is a short-acting ester that delivers an initial testosterone peak within the first few days after injection. Testosterone cypionate and testosterone enanthate are longer-acting esters that sustain testosterone levels for an extended period.
Once each esterified compound is released and metabolized, the active hormone is testosterone. The ester primarily influences the rate of release and duration of activity rather than changing the underlying anabolic and androgenic properties of testosterone itself.
These characteristics explain why multi-ester testosterone blends are encountered both in medically supervised testosterone replacement therapy and in non-medical bodybuilding settings where a longer-acting testosterone preparation with a mixed release profile is commonly preferred.
The combination of short and long-acting esters in Testo Blend 350 mg produces a multi-phase release profile. The propionate ester provides rapid onset, while the cypionate and enanthate esters sustain testosterone levels between injections, which is often referenced as an advantage for less frequent administration compared to single short-acting esters.
Dragon Pharma offers several testosterone formulations built around different esters, concentrations and release profiles. The main practical distinction between these preparations is how quickly testosterone is released and how long the formulation remains active after administration.
Enantat 250 and Cypionate 250 use single long-acting esters for gradual release. Sustanon 270 combines five testosterone esters with different release rates. Testabol 400 combines three testosterone esters (acetate, enanthate, and decanoate) at a higher total concentration of 400 mg/mL. Propionat 100 uses a single short-acting ester requiring more frequent injections.
Published laboratory reports for Testo Blend 350 mg are shown below with the test date, measured total concentration and percentage of the product's 350 mg/mL label claim.
View Report
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. Testosterone blends are prescription androgens; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In medically supervised testosterone replacement therapy, multi-ester testosterone blend dosing is individualized based on laboratory results, symptom response and the specific product used. In non-medical bodybuilding settings, Testo Blend 350 mg is commonly referenced in the range of 250–500 mg per week, often administered once or twice weekly due to the multi-ester release profile, though such use falls outside approved medical indications.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| TRT (medical) | Individualized by clinician | Once weekly to once every 2 weeks |
| Bodybuilding (non-medical) | 250–500 mg / week | Once or twice weekly |
| Stacking base compound | Typically combined with other compounds | Per cycle protocol |
In non-medical bodybuilding contexts, multi-ester testosterone blends are frequently used as a base compound in bulking or mass-building cycles and may be combined with other injectable or oral compounds. Dragon Pharma offers several products that are commonly referenced in this context, including Deca 300 and Dianabol 20 for bulking, or Winstrol 10 during cutting phases where maintaining muscle while reducing fat is a goal.
As with any testosterone preparation, cycle structure, duration and support compounds should be considered in the context of individual experience, health status and bloodwork where possible.
Testosterone blends aromatize, meaning some of the testosterone converts to estrogen. This can contribute to water retention, gynecomastia and elevated blood pressure in susceptible individuals. Aromatase inhibitors such as Arimidex are commonly referenced in this context, though use should be based on individual response and bloodwork where possible.
Testosterone blends are not liver toxic in the way oral C17-alpha-alkylated steroids are, but cholesterol and hematocrit levels should be monitored during use.
After completing a cycle with Testo Blend 350 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Multi-ester testosterone blends are prescription androgens that can affect hormonal, reproductive, cardiovascular and hematologic function. Medical testosterone therapy requires appropriate diagnosis, clinical supervision and ongoing monitoring.
Testosterone replacement therapy is intended for appropriately diagnosed testosterone deficiency. Clinical evaluation normally considers both compatible symptoms and consistently low testosterone concentrations rather than symptoms alone.
Use of testosterone blends at supraphysiologic levels for bodybuilding or performance enhancement falls outside approved replacement therapy and can increase exposure to androgen-related adverse effects.
Higher-than-physiologic testosterone exposure can carry additional health risks. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Testosterone therapy can increase red blood cell production and hematocrit. Excessive elevation can require medical evaluation and changes to treatment. Monitoring may also include blood pressure, prostate-related assessment and evaluation for other treatment-related adverse effects.
Testosterone can suppress the body's own reproductive hormone signaling and reduce sperm production. Fertility is therefore an important consideration, particularly for men planning to have children.
Other potential androgen-related effects can include acne, changes in skin oil production, fluid retention and changes in prostate-related symptoms. Individual response and risk vary according to health status, exposure and other factors.
Testosterone therapy is not appropriate for everyone. Medical guidelines identify circumstances in which treatment should be avoided or carefully evaluated, including known or suspected prostate or male breast cancer, elevated hematocrit, untreated severe obstructive sleep apnea, certain cardiovascular conditions, thrombophilia and near-term fertility plans.
Existing cardiovascular disease, urinary or prostate symptoms, abnormal blood counts and other medical conditions should be discussed with a qualified healthcare professional before testosterone therapy is considered.
Medically supervised testosterone therapy typically involves follow-up assessment to evaluate treatment response, adverse effects and relevant laboratory markers. Depending on the individual, monitoring may include testosterone concentrations, hematocrit and prostate-related evaluation.
Laboratory testing of the product itself, such as the published potency reports shown in the Lab Reports tab, is separate from clinical monitoring of the person using testosterone.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Testo Blend 350 mg is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Dragon Pharma distribution chain.
To verify your Testo Blend 350 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Official Dragon Pharma presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Testo Blend 350 mg, the three-ester testosterone blend, release characteristics, product strength and laboratory testing.
Testo Blend 350 mg contains a blend of three testosterone esters. In medical practice, multi-ester testosterone blends are used for appropriately diagnosed testosterone deficiency. In non-medical bodybuilding settings, it is commonly referenced as a base compound for muscle growth, strength and recovery due to its mixed release profile, though such use falls outside approved medical indications.
Because of its multi-ester release profile, Testo Blend 350 mg is typically referenced as being administered once or twice weekly in non-medical contexts, though some protocols reference less frequent injections due to the long-acting cypionate and enanthate esters. In medically supervised therapy, injection frequency is individualized by a clinician based on laboratory results and treatment response.
Testo Blend 350 mg contains three testosterone esters that release testosterone at different rates after injection. Once the esterified compounds are released and metabolized, the active hormone is testosterone, which has both androgenic and anabolic effects. Testosterone supports muscle mass, strength, sexual function and other androgen-dependent physiological processes. Non-medical use for bodybuilding or performance enhancement falls outside approved testosterone replacement therapy.
Testo Blend 350 mg contains both short and long-acting testosterone esters. The short-acting propionate ester provides an initial testosterone peak within the first few days after injection, while the longer-acting cypionate and enanthate esters sustain testosterone levels over an extended period. The time required to notice a change depends on what is being evaluated and other individual factors.
There is no single testosterone formulation that is universally best. Multi-ester blends offer a mixed release profile that may reduce injection frequency while providing both rapid and sustained testosterone levels. Single-ester preparations such as enanthate, cypionate, or propionate offer different release characteristics. The appropriate formulation depends on the circumstances in which testosterone is being used.
Sustanon 270 combines five testosterone esters (acetate, propionate, phenylpropionate, isocaproate, and decanoate) at a total concentration of 270 mg/mL. Testo Blend 350 mg combines three testosterone esters (propionate, cypionate, and enanthate) at a higher total concentration of 350 mg/mL. The choice between them depends on the desired release profile, concentration, and individual goals.
Testabol 400 combines three testosterone esters (acetate, enanthate, and decanoate) at a total concentration of 400 mg/mL. Testo Blend 350 mg combines three different testosterone esters (propionate, cypionate, and enanthate) at a total concentration of 350 mg/mL. Both are multi-ester blends, but the specific esters and concentrations differ, which may influence the release profile and injection frequency. The appropriate formulation depends on individual preferences and cycle considerations.
A milligram amount cannot be classified as appropriate or excessive without considering the medical indication, individual response, laboratory results, treatment schedule and the specific testosterone product being used. Testosterone treatment should therefore be individualized by a qualified healthcare professional.
It is also important to distinguish a dose in milligrams from a product's concentration in mg/mL. Testo Blend 350 mg is labeled at 350 mg/mL; that concentration does not by itself specify how much should be administered.
Testo Blend 350 mg is labeled at 350 mg of total testosterone esters per mL. It is supplied in a 10 mL vial, giving 3,500 mg of total labeled testosterone ester content per vial.
Yes. A published laboratory report dated March 25, 2026 measured Testo Blend 350 mg at 346.63 mg/mL, equivalent to 99.04% of its 350 mg/mL label claim.
An additional report from April 18, 2025 (378.24 mg/mL, 108.07%) is also available. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.
Enantat 250 contains a single long-acting testosterone ester (enanthate) at a concentration of 250 mg/mL. Testo Blend 350 mg is a multi-ester blend containing propionate, cypionate, and enanthate esters at a higher total concentration of 350 mg/mL, offering a broader range of release rates from a single injection. The appropriate formulation depends on individual preferences and cycle considerations.